Trial intelligence / Profile preview

PRE-POINT-EARLY Study

2014-005287-15Phase 2Completed

Sponsor
Technical University of Munich Faculty of Medicine
Start
Apr 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by Technical University of Munich Faculty of Medicine. Primary endpoint: Development of islet autoimmunity or diabetes. Started Apr 2015; status: completed.

02

Drugs

human insulin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2014-005287-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005287-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call